CanWell Pharma Inc.
- Biotech or pharma, therapeutic R&D
A venture-backed, mid-late clinical stage company focused on development of novel immuno-oncology, multiple/dual-payload ADC , bispecific dual-payload ADC and TLR7-ADC products utilizing our novel StarLinker multiple-payload conjugation platforms to targeted cancers and develop products to address highly unmet medical needs. We have a rare disease mid-late stage opportunity with the potential for breakthrough designation in the US.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}